Markets:

Overview

News

Currencies

International

Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

1.070 +0.020 (+1.90%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

SciSparc To Collaborate With Polyrizon For Brain Targeting Using Intranasal Hydrogel Systems ↗

May 31, 2022

SciSparc will use its SCI-160 technology platform for treating pain in combination with Polyrizons' Trap and TargetTM technology

Via Benzinga

70 Biggest Movers From Friday ↗

May 31, 2022

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for...

Via Benzinga

SciSparc Announces $10M Private Offering ↗

May 27, 2022

SciSparc Ltd.

Via Benzinga

SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial In Tourette Syndrome ↗

May 26, 2022

Ethics Committee approval received from the two sites that will conduct the SCI-110 trial in Germany and Israel

Via Benzinga

SciSparc And Clearmind Medicine Inc. Collaboration Yields Positive Results For Its Psychedelic Combination Treatment ↗

May 24, 2022

Pre-clinical trials based on the proprietary combination demonstrate significant suppressive effect on alcohol consumption

Via Benzinga

SciSparc Gets Ethics Committee Approval In Germany And Israel Sites To Conduct A Phase IIb Trial In Tourette Syndrome ↗

May 27, 2022

Image sourced from Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

20 Stocks Moving in Friday's Pre-Market Session ↗

May 27, 2022

Gainers Adicet Bio, Inc. (NASDAQ: ACET) rose 16% to $11.90 in pre-market trading after reporting positive clinical update from ADI-001 Phase 1 Trial in relapsed/refractory Non-Hodgkin’s Lymphoma.

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 575 Points; Apyx Medical Shares Spike Higher ↗

May 26, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 575 points on Thursday.

Via Benzinga

Mid-Day Market Update: Crude Oil Jumps Over 3%; NRx Pharmaceuticals Shares Tumble ↗

May 26, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 1.5% on Thursday.

Via Benzinga

SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders ↗

May 17, 2022

Patent extends protection for SciSparc’s novel compounds and methods already granted in the US, Australia and Japan

Via Benzinga

88 Biggest Movers From Yesterday ↗

May 27, 2022

Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.

Via Benzinga

61 Stocks Moving In Thursday's Mid-Day Session ↗

May 26, 2022

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; US Economy Contracts 1.5% In Q1 ↗

May 26, 2022

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 200 points on Thursday.

Via Benzinga

Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028

May 26, 2022

Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis,...

Via FinancialNewsMedia

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 26, 2022

Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

20 Stocks Moving in Thursday's Pre-Market Session ↗

May 26, 2022

Gainers TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares rose 51.2% to $0.9603 in pre-market trading after dipping 18% on Wednesday.

Via Benzinga

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

May 25, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) gained 178.3% to $0.3762 as the company announced it increased retail distribution across Canada with Loblaw Companies.

Via Benzinga

Positive Phase 2 Results Of SciSparc's Cannabinoid-Based Drug Candidate May Offer Some New Hope To Tourette Syndrome Patients ↗

May 25, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 25, 2022

Rise and shine, traders! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

21 Stocks Moving in Wednesday's Pre-Market Session ↗

May 25, 2022

Gainers The Singing Machine Company, Inc. (NASDAQ: MICS) shares rose 47.3% to $4.05 in pre-market trading.

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 25, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Down 300 Points; America's Car-Mart Shares Spike Higher ↗

May 24, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 300 points on Tuesday.

Via Benzinga

Mid-Day Market Update: Dow Drops Over 200 Points; CynergisTek Shares Jump ↗

May 24, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.

Via Benzinga

Psychedelic Treatment For Alcoholism? Clearmind Medicine And SciSparc Collaboration Yields Positive Results ↗

May 24, 2022

Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0) a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems,...

Via Benzinga

SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis ↗

May 18, 2022

Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

May 24, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.

Via Benzinga

Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested ↗

May 13, 2022

On Wednesday, May 18, Clearmind Medicine Inc. (OTC Pink: CMNDF) will meet with the Center for Drug Evaluation and Research (CDER), a department within the FDA.

Via Benzinga

23 Stocks Moving in Friday's Pre-Market Session ↗

May 13, 2022

Gainers OTR Acquisition Corp. (NASDAQ: OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed shareholders approved merger with Comera Life Sciences.

Via Benzinga

Global Psychedelics Market Is Expected To Reach $8 Billion By 2029

May 24, 2022

Palm Beach, FL – May 24, 2022 – FinancialNewsMedia.com News Commentary – The Global psychedelic drugs market has been steadily rising for the past few years and is projected to continue at a faster...

Via FinancialNewsMedia

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

All News about SciSparc Ltd. - Ordinary Shares

Starting at $3.75/week.

Subscribe Today